Your doctor may prescribe a type of drug called a cholinesterase inhibitor, most commonly donepezil (Aricept), rivastigmine (Exelon), or galantamine (Razadyne). By blocking breakdown of an important ...

Wall Street expects a year-over-year decline in earnings on higher revenues when Exelon (EXC) reports results for the quarter ended December 2024. While this widely-known consensus outlook is ...

Exelon boosts capex plan by $3.5 billion, mostly to bolster power lines Major U.S. electric utility Exelon increased its four-year capital investment plan by 10% to $38 billion, with the bulk of ...

Morgan Stanley analyst David Arcaro maintained a Hold rating on Exelon (EXC – Research Report) today and set a price target of $46.00. The company’s shares closed yesterday at $42.65.